For example, Desikan et al. [61] showed that amongst APOE ε3/3 carriers, PRS modified the expected age of AD onset by more than 10 years between the lowest and highest deciles (hazard ratio 3.34, p = 10−22). This evidence concerns the gene APOE and Alzheimer disease.